Efficacy News and Research

RSS
FDA responds to EpiCept Ceplene SPA

FDA responds to EpiCept Ceplene SPA

Spectranetics initiates enrollment in EXCITE clinical trial against femoropopliteal IRS

Spectranetics initiates enrollment in EXCITE clinical trial against femoropopliteal IRS

Yissum, BioLineRx sign license deal to develop and commercialize BL-7040 for IBD

Yissum, BioLineRx sign license deal to develop and commercialize BL-7040 for IBD

Enrollment complete in ERYTECH Pharma's Graspa Phase I clinical trial for pancreatic cancer

Enrollment complete in ERYTECH Pharma's Graspa Phase I clinical trial for pancreatic cancer

Positive data from Lyxumia study on type 2 diabetes presented at ADA 2011

Positive data from Lyxumia study on type 2 diabetes presented at ADA 2011

Video monitors on public buses to help raise HIV testing awareness among African Americans

Video monitors on public buses to help raise HIV testing awareness among African Americans

Positive preliminary findings from ATI's neurostimulation system study on cluster headache

Positive preliminary findings from ATI's neurostimulation system study on cluster headache

Mortality, morbidity rates linked with AF remain 'unacceptably high' despite new treatments

Mortality, morbidity rates linked with AF remain 'unacceptably high' despite new treatments

New model estimates impact of lifestyle changes on absolute breast cancer risk

New model estimates impact of lifestyle changes on absolute breast cancer risk

Intravenous diclofenac holds promise against severe pain following oral surgery

Intravenous diclofenac holds promise against severe pain following oral surgery

Diabetic patients can benefit from basal insulin analogs

Diabetic patients can benefit from basal insulin analogs

Short-term lowering of PreDx DRS may reduce risk of developing diabetes

Short-term lowering of PreDx DRS may reduce risk of developing diabetes

New data from Zafgen's ZGN-433 Phase 1b study on obesity presented at ADA 2011

New data from Zafgen's ZGN-433 Phase 1b study on obesity presented at ADA 2011

EMA CHMP recommends approval of linagliptin for type 2 diabetes

EMA CHMP recommends approval of linagliptin for type 2 diabetes

Scientific evidence is key driver for gaining reimbursement for MR-guided focused ultrasound

Scientific evidence is key driver for gaining reimbursement for MR-guided focused ultrasound

EMA CHMP issues positive opinion for Baxter's IVIG therapy for multifocal motor neuropathy

EMA CHMP issues positive opinion for Baxter's IVIG therapy for multifocal motor neuropathy

PCIB reports main results of Amphinex Phase I/II study against multiple cancers

PCIB reports main results of Amphinex Phase I/II study against multiple cancers

Scientists analyse factors that influence development of burnout syndrome

Scientists analyse factors that influence development of burnout syndrome

Lithium can prevent aggregation of toxic proteins and cell loss linked with Parkinson's

Lithium can prevent aggregation of toxic proteins and cell loss linked with Parkinson's

Electrophysiology mapping and ablation devices market to reach over $2.1B by 2017

Electrophysiology mapping and ablation devices market to reach over $2.1B by 2017

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.